Jeuveau

Also known as: Jeuveau, prabotulinumtoxinA, neuromodulator, botulinum toxin type A

Neurotoxins & Dermal Fillers

AI Aesthetician Summary

Jeuveau (prabotulinumtoxinA) is a prescription injectable neuromodulator that represents the newest advancement in botulinum toxin type A treatments for facial aesthetics. Approved by the FDA in 2019, Jeuveau was the first new neurotoxin for cosmetic use to receive FDA approval in over a decade, ear...

Treatment Details

Targets

Concerns:Frown Lines Crow's Feet Wrinkles Neck Wrinkles Sweaty Armpits Hooded Eyes

Areas:Eye, Forehead, Jaw, Neck, Armpit

Tissues:Muscle/SMAS

Longevity:3-6 Months

How it Works

Duration:15 minutes

Anesthesia:None

Pain Level:Mild

Techniques:Injection

Session Notes:Results typically begin within a few days and reach full effect by two weeks; consider follow-up at ~2 weeks for touch-ups if needed. Inform the provider of pregnancy, breastfeeding, neuromuscular disorders, or interacting medications prior to treatment. Dosing and injection sites are individualized based on anatomy and treatment goals.

Post Treatment

Downtime:0 days

Risks:Common risks include temporary bruising, redness, swelling, headache, or localized pain. Less commonly, toxin diffusion can cause ptosis (drooping eyelid), asymmetry, or unwanted muscle weakness. Rare allergic reactions or systemic effects are possible.

Additional Information

Invasiveness:Minimally Invasive

Manufacturer:Evolus

Specialty:Medical Spa

Research